Cost-Effectiveness Analysis of Antiviral Pharmacotherapies for Treatment of Chronic Hepatitis C Virus Infection in Russia

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.821
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2019English

Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis-C Virus Infection in Venezuela

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Treatment Options for Chronic Hepatitis C Virus Infection

Medicinski Pregled
Medicine
2006English

Points: Antiviral Treatment in Chronic Infection With Hepatitis B Virus

BMJ
1986English

Value in Hepatitis C Virus Treatment: A Patient-Centered Cost-Effectiveness Analysis

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2019English

Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in Canada

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Boceprevir in the Treatment of Chronic Hepatitis C Virus Infection

Virus Adaptation and Treatment
VirologyInfectious DiseasesImmunology
2011English

Cost-Effectiveness of Access Expansion to Treatment of Hepatitis C Virus Infection Through Primary Care Providers

Gastroenterology
HepatologyGastroenterology
2017English

Cost Effectiveness of Fibrosis Assessment Prior to Treatment for Chronic Hepatitis C Patients

PLoS ONE
Multidisciplinary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy